Skip to content
thestock.space

As of 6 Nov 2026, Pentokey Organy (India) is loss-making on a trailing 12-month basis, with a net loss of ₹0.06 Cr, so it has no P/E ratio. The share price is ₹28.27, 50% below its 52-week high. Sales fell 22% a year over 3 years. It is a small-cap company with a market cap of ₹18 Cr, ranked 73rd of 76 Chemicals companies by market cap; the shares fell 45% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹28.12
Day high
₹28.27
Day low
₹28.12
Prev. close
₹28.99
Volume
321

Health check

1 fair · 5 to check
  • ReturnsBehind

    −44.8% over a year, better than 0 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • GrowthShrinking

    Sales −21.8%, profit −60.0% a year over 3 years.

  • ProfitabilityWeak

    ROCE 2.1% vs peer median 10.6%.

  • Balance sheetFair

    Practically debt-free, Piotroski 5 of 9.

  • Red flags5 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹18 Cr, #73 of 76 in its industry by size.

Defensive

Beta 0.50 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹−3 Cr · profit ₹−0 Cr
Market cap
₹18 Cr
Small cap
P/E
n/a
Industry 18.2
Price to book
0.72
Peers 2.62
Dividend yield
0.00%
ROE
2.1%
Peers 11.7%
ROCE
2.1%
Peers 10.6%
Debt to equity
−0.00
Debt −₹0.01 Cr
EPS (TTM)
−₹0.35
OPM (TTM)
17.3%
Net margin 0.0%
Sales growth
n/a
Year-ago quarter not reported
Profit growth
−55.2%
Latest quarter vs a year ago
Price to sales
−5.97

Strengths and risks

Strengths

  • Practically debt-free.

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at 2.1%.
  • Quarterly profit down 55.2% on a year ago.
  • 50% below its 52-week high.
  • Interest coverage of only −288.4×.

Derived automatically from reported figures. Not a recommendation.

About Pentokey Organy (India)

Pentokey Organy (India) Limited engages in trading of pharmaceutical products in India. It also trades fertilizers and pesticides products. Pentokey Organy (India) Limited was incorporated in 1986 and is based in Mumbai, India.

Headquarters
Mumbai
Employees
3
Sector
Basic Materials
ISIN
INE702E01015
Website
pentokey.com

Price range

52 weeks

₹25.00₹57.00

Today

₹28.12₹28.27
Avg volume (3M)
769
1-year return
minus 44.8%
From 52-week high
minus 50.4%

Peers · Chemicals

Capital-heavy industry columns

Compare with peersScreen the whole industry
Company
NAVINFLUORNavin Fluorine International9,010.00plus 1.87%46,25050.842.718.7%34.3%0.2816.5%plus 46.1%
DEEPAKNTRDeepak Nitrite1,533.60minus 0.67%20,91719.722.310.8%18.0%0.27−0.5%minus 11.9%
TATACHEMTata Chemicals607.45minus 1.36%15,475–12.4−3.0%12.2%0.36−4.8%minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.1,155.30minus 0.69%14,59914.811.511.2%17.6%0.762.6%minus 22.7%
RPELRaghav Productivity Enhancers1,780.80plus 0.95%8,178116.0107.1–29.9%0.0223.5%plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals451.80minus 1.87%6,6396.35.410.4%14.8%0.01−8.8%minus 7.2%
ACIArchean Chemical Industries416.40minus 1.95%5,14151.323.27.7%20.0%0.28−9.2%minus 34.6%
PNTKYORPentokey Organy (India)28.27minus 2.48%18––2.1%17.3%−0.00−21.8%minus 44.8%
Median of 7 peers–−0.69%14,59935.222.310.6%18.0%0.28−0.5%−11.9%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
5.11−2.1−1.9–
4.60.9−1.7−1.6–
0.40−0.4−0.30.1
8.8%3.7%18.1%16.5%–
00.10.10.20.1
––00–
0.50.1−0.3−0.10.2
0.50.1−0.3−0.10.2
0.770.23-0.47-0.460.35

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
−21.8%
Profit CAGR 3Y
−60.0%
EPS CAGR 3Y
−57.8%
ROE
2.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4.44.40.82.1
–+0.7%minus 81.2%+153.0%
3.53.912.3
0.90.5−0.2−0.2
20.7%10.6%−25.7%−9.7%
0.30.40.50.4
0000
000–
2−0−00
3.20.90.20.2
3.20.90.20.2
–minus 72.5%minus 71.9%minus 17.2%
5.061.390.390.38

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
6.36.36.36.3
2.133.23.4
–––−0
0.50.20.3−0.3
8.99.59.89.4
000–
001.21.3
4.55.54.96
4.443.72.1
8.99.59.89.4

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0.10.60.20.8
0.2−0.6−0.21.4
−0−0−0−0
0.1−002.2
−0.10.60.20.8

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders. Institutions hold about 2.2% (Yahoo estimate).

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you